Pharming Group is a biopharmaceutical company based in the Netherlands that develops and makes protein-based medicines for rare diseases. Its main product is a recombinant treatment for hereditary angioedema, a genetic condition that causes sudden swelling, and the company also works on therapies for other immune and inflammatory disorders. Its customers are mainly hospitals, specialist physicians and patients in Europe and North America, and it handles manufacturing and commercial supply itself.
Pharming Group N.V. trades under the code 0QCO on the London Exchange in UK, with its price quoted in euros (EUR). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Weak price profile
Ranks #3332 of 3787 on the London Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for UK yet.
TrendWeak
15/100
Below its long-term averages and far from its highs.
See the numbers →
Above 200-day average-16.3%
From 52-week high-42.1%
MomentumWeak
20/100
Lagging most stocks on this exchange.
See the numbers →
3-month return-10.2%
6-month return-30.9%
12-month, skipping last month-19.1%
Stability (higher is calmer)Weak
19/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)60.3%
Worst drawdown, 1 year (smaller is calmer)-52.6%
LiquidityFair
51/100
Moderate trading activity.
See the numbers →
Avg daily value traded0.83M EUR
Zero-volume days3.3%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for UK when fundamentals data for this market is added. All UK stocks.
52-wk range 0.823 – 1.827Daily closes, split-adjusted
Signals
50-day average0.932
200-day average1.200
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.139
Technical summary
Daily
Neutral
7 bullish · 3 neutral · 6 bearish
Weekly
Bearish
3 bullish · 1 neutral · 8 bearish
Monthly
Strongly bearish
1 bullish · 1 neutral · 6 bearish
Moving averages (daily)
SMA 10
0.87
Bullish
EMA 10
0.89
Bullish
SMA 20
0.88
Bullish
EMA 20
0.89
Bullish
SMA 50
0.93
Bullish
EMA 50
0.93
Bullish
SMA 100
1.02
Bearish
EMA 100
1.01
Bearish
SMA 200
1.20
Bearish
EMA 200
1.10
Bearish
Oscillators (daily)
RSI (14)
67.92
Neutral
MACD (12, 26)
-0.01
Bearish
Momentum (12)
17.50
Bullish
Stochastic %K (14)
49.20
Neutral
Williams %R (14)
-50.80
Neutral
CCI (20)
216.5
Bearish
Pivot points (classic, last session)
S3
0.75
S2
0.88
S1
0.94
Pivot
1.07
R1
1.13
R2
1.25
R3
1.32
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in EUR. Educational only, not financial advice.
